This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2021 Feb;159(2):459-461.

doi: 10.1016/j.chest.2020.10.062.

Time for a Paradigm Shift

Hitasha Rupani¹

Affiliations

Affiliation

¹ Portsmouth Severe Asthma Service, Respiratory Department, Portsmouth Hospitals University NHS Trust, Portsmouth, England. Electronic address: h.rupani@nhs.net.

PMID: 33563426
DOI: 10.1016/j.chest.2020.10.062

Editorial

Time for a Paradigm Shift

Hitasha Rupani. Chest. 2021 Feb.

. 2021 Feb;159(2):459-461.

doi: 10.1016/j.chest.2020.10.062.

Author

Hitasha Rupani¹

Affiliation

¹ Portsmouth Severe Asthma Service, Respiratory Department, Portsmouth Hospitals University NHS Trust, Portsmouth, England. Electronic address: h.rupani@nhs.net.

PMID: 33563426
DOI: 10.1016/j.chest.2020.10.062

No abstract available

PubMed Disclaimer

Comment on

Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma.
Kavanagh JE, Hearn AP, Dhariwal J, d'Ancona G, Douiri A, Roxas C, Fernandes M, Green L, Thomson L, Nanzer AM, Kent BD, Jackson DJ. Kavanagh JE, et al. Chest. 2021 Feb;159(2):496-506. doi: 10.1016/j.chest.2020.08.2083. Epub 2020 Aug 31. Chest. 2021. PMID: 32882249

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations